{"id":"NCT03328897","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria","officialTitle":"A Phase III Study to Evaluate the Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-04-26","primaryCompletion":"2019-07-23","completion":"2019-09-24","firstPosted":"2017-11-01","resultsPosted":"2020-11-04","lastUpdate":"2020-11-04"},"enrollment":418,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Spontaneous Urticaria"],"interventions":[{"type":"DRUG","name":"Omalizumab","otherNames":["IGE025"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Omalizumab 300mg","type":"EXPERIMENTAL"},{"label":"Omalizumab 150mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to demonstrate the efficacy and safety of omalizumab, compared with placebo, as an add-on to H1 antihistamines (H1AH) therapy in adult patients suffering from Chronic Spontaneous Urticaria (CSU) who remained symptomatic despite H1AH therapy.","primaryOutcome":{"measure":"Change From Baseline of the Itch Severity Score (ISS7) Score After 12 Weeks of Treatment","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Omalizumab 300mg","deltaMin":-10.11,"sd":0.43},{"arm":"Omalizumab 150mg","deltaMin":-9.66,"sd":0.424},{"arm":"Placebo","deltaMin":-5.87,"sd":0.604}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":27,"countries":["China"]},"refs":{"pmids":["33865434"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":167},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Cough","Influenza","Blood uric acid increased"]}}